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INTRODUCTION
Verruciform xanthoma (VX) is an uncommon reactive papillary exophytic lesion first described in 1971 1 . Clinicians usually do not include VX in the differential diagnosis of papillary growths affecting the oral mucosa and, as it can resemble infectious, reactive and potentially malignant/malignant disorders, it is advisable that this condition should be recognized and included as a differential diagnosis in this situation. The aim of the present study is to report a VX affecting the gingiva calling attention to the importance of considering this entity in the differential diagnosis of oral papillary swellings.
CASE REPORT
A 66-year-old Afro-American female was referred for evaluation of a painless papillary growth on the anterior gingiva lasting 15 days. Medical history included controlled systemic hypertension managed with hydrochlorotiazide and hydralazine. Oral examination revealed a 1,2 x 0,6 cm painless firm exophytic papillary slightly reddish growth in the free buccal gingival margin of the upper right central incisor (Fig. 1A) .
Clinical differential diagnosis included papillary gingival hyperplasia, condiloma acuminatum and VX. An excisional biopsy was performed under local anesthesia and histological analysis of the 5 µm hematoxylin and eosin stained histological slides showed a proliferative parakeratinized stratified squamous epithelium with papillary surface and long and thin projections to the adjacent connective tissue ( Fig. 2A and 2B ). Xanthomatous cells with large vesicular and granular cytoplasm occupied the papillary superficial connective tissue ( Fig. 2B and 2C ). Immunohistochemical analysis showed that these cells were CD68 positive (Fig. 2D) , confirming their macrophage origin, and final diagnosis was VX. Post-surgical recovery was uneventfully and the patient remains in clinical follow-up without any signs of local recurrence for 6 months (Fig. 1B and 1C) .
The authors declare that they have followed the Declaration of Helsinki and all ethical requirements.
DISCUSSION
Most VX affect the oral cavity but some cases have been reported in the skin and other mucosal surfaces. Clinical presentation of oral VX usually includes painless isolated reddish to whitish exophytic papillary growths measuring less than 2.0 cm mostly affecting adult males [2] [3] [4] [5] . The most common oral locations are the gingiva, alveolar mucosa and palate [3] [4] [5] and, although most VX are isolated lesions, some multiple cases affecting the oral cavity, especially the gingiva, have been reported 6 . Although the clinical picture is suggestive, few clinicians have raised the suspicion of VX during treatment planning of papillary exophytic lesions. Differential diagnosis should include mainly squamous papilloma, verruca vulgaris, spongiotic gingival hyperplasia, verrucous hyperplasia and early verrucous carcinoma and papillary squamous cell carcinoma [2] [3] [4] 7, 8 . As final diagnosis is based on histological analysis, suspicion of VX when dealing with the differential diagnosis of oral papillary lesions is advisable for adequate treatment.
Pathogenesis of VX is still unknown but local trauma is considered the major etiological factor. The condition has been reported as secondary to other diseases associated with epithelial integrity disruption, such as graft versus host disease, pemphigus vulgaris and lichen planus 4, 8 . Histologically VX is characterized by the presence of epithelial proliferation, acanthosis, parakeratosis and elongated rete ridges, associated with a papillary/verrucous surface of the stratified squamous surface epithelium with the crypts plugged with parakeratin 2, 9, 10 . Xanthomatous CD68+/cathepsin B+ macrophages with a large vesicular to granular lipid-rich cytoplasm and a rounded central or displaced nucleus occupy the connective tissue papillae among the rete ridges 3, 9 . Treatment of VX is established with conservative surgical excision and no recurrences are expected after complete removal 2, 4 . In conclusion, VX should be included in the differential diagnosis of oral gingival papillary swellings for adequate treatment planning and proper management.
